Second Opinion: Cancer and Cardiotoxicity

Cardiologist, Christopher Fine, MD and hematologist/oncologist Mohammed Salhab, MD discuss the management of cardiotoxicity resulting from immune checkpoint inhibitor therapy in patients with cancer.